Commercial Metals (CMC)
NYSE: CMC
· Real-Time Price · USD
59.72
-0.71 (-1.17%)
At close: Oct 15, 2025, 3:59 PM
59.69
-0.04%
After-hours: Oct 15, 2025, 04:30 PM EDT
-1.17% (1D)
Bid | 59.24 |
Market Cap | 6.68B |
Revenue (ttm) | 7.68B |
Net Income (ttm) | 36.81M |
EPS (ttm) | 0.3 |
PE Ratio (ttm) | 199.05 |
Forward PE | 11.63 |
Analyst | Hold |
Dividends | $0.9 |
Ask | 59.8 |
Volume | 1,594,765 |
Avg. Volume (20D) | 974,709.3 |
Open | 61.00 |
Previous Close | 60.43 |
Day's Range | 58.59 - 61.00 |
52-Week Range | 37.92 - 64.53 |
Beta | 1.32 |
Ex-Dividend Date | Jun 30, 2025 |
Analyst Forecast
According to 0 analyst ratings, the average rating for CMC stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock ForecastsCommercial Metals is scheduled to release its earnings on
Oct 16, 2025,
before market opens.
Analysts project revenue of ... Unlock content with Pro Subscription
Analysts project revenue of ... Unlock content with Pro Subscription
2 days ago
+3.74%
Shares of iron and steel-related stocks are tradin...
Unlock content with
Pro Subscription
5 days ago
-3.44%
Shares of steel companies are trading lower amid overall market weakness after President Trump, on a social media post, said that he is considering an increase in tariffs on Chinese products.

2 weeks ago · proactiveinvestors.co.uk
CMC Markets expects 'meaningful' revenues from expanded Westpac partnership in AustraliaCMC Markets PLC (LSE:CMCX) shares climbed 6% on news that it has been selected as preferred vendor by Australia's Westpac for online share price trading services, extending an existing relationship Do...

2 months ago · seekingalpha.com
Unicycive Therapeutics: Manageable CMC Speed-Bump--Pill-Burden Edge Intact, BuyingInitiating coverage on Unicycive Therapeutics, Inc. with a Buy rating and $6 price target, as the recent FDA CRL is manufacturing-related and resolvable. OLC's ultra-low pill burden and strong patient...